Can magnetocardiography detect patients with non‐ST‐segment elevation myocardial infarction?
Hyun Kyoon Lim(Korea Research Institute of Standards and Science), Yong Ki Park(Korea Research Institute of Standards and Science), Boyoung Joung(Yonsei University), Jung‐Rae Cho(Yonsei University), Young‐Guk Ko(Yonsei University Health System), Yong‐Ho Lee(Korea Research Institute of Standards and Science), Kiwoong Kim(Chungbuk National University), Inseon Kim(ETH Zurich), Namsik Chung(Yonsei University), Jin‐Bae Kim(Yonsei University), Kwon Kyu Yu(Korea Research Institute of Standards and Science), Jin‐Mok Kim(Korea Research Institute of Standards and Science)
Cited by 38
Related Papers
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
|The Lancet|2019|3.1k
A New Strategy for Discontinuation of Dual Antiplatelet Therapy
|Journal of the American College of Cardiology|2012|643
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
|The Lancet|2019|640